When I was in my latter teens I obtained a training position in the advertising department of the Chatham Daily News, my proponent being my homeroom teacher at…
What’s cooking in the IPO kitchen?
Voyager Life, the health and wellness company established to supply high-quality Cannabidiol (CBD) and hemp seed oil products, announces the Company s intention to seek admission to trading on the Aquis Stock Exchange Growth Market (Access Segment). Admission on AQSE is expected to occur before the end of June 2021. Voyager was incorporated in November 2020 as a health and wellness business focused on CBD and hemp seed oil products. The Company s directors believe that a significant opportunity exists in the CBD market due to the forecast growth and ongoing regulatory changes.
Galantus Holdings, a provider of accounts payable automation and analytics solutions, is considering a listing on the AIM market of the LSE. It is focusing on three product areas; Active AP Discovery, Intelligent AP Automation and Advanced AP Analytics, it utilises its internally developed data platform to offer an integrated solution for the finance function, accounts
PREMIUM
The Current Health monitor remotely collects data on a variety of vital signs to predict the onset and progression of disease By Kristy Dorsey Edinburgh start-up Current Health has raised $43 million (£31m) in what is believed to be largest Series B funding round in Scottish tech history. The cash will allow the company, whose platform delivers healthcare in the home, to more than double headcount with the creation of 100 new jobs by the end of this year. About half of these will be data science and software engineering posts based in Edinburgh, where it currently employs 50 of its 90 staff.
Scottish medtech Current Health raises £31m to create 100 jobs heraldscotland.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from heraldscotland.com Daily Mail and Mail on Sunday newspapers.
By Kristy Dorsey Scottish digital health company Altair Medical has secured £2.25 million in a first round of funding to bring its real-time platform for monitoring breathing problems to the market as early as next year. The money has been raised from a syndicate of investors including the Scottish Investment Bank, Intuitive Investment Group and angel investor syndicates Equity Gap, Alba Equity, and London & Scottish Investment Partners. It will allow Altair, based at Eurocentral off the M8 motorway, to double its workforce to 12 in the coming months. The monitoring platform, which has yet to be given a commercial name, includes a small re-usable biosensor that transmits data to a cloud platform using a data hub or smartphone. Capable of accurately monitoring large numbers of people in any location, it automatically alerts patients, their household members or medical professionals when life-threatening changes occur.